El año pasado, Perrigo Company PLC generó 270.90M USD en su segmento con mejor rendimiento, Contract Manufacturing. United States realizó la mayor aportación, representando 2.54B USD el año pasado. Para el último trimestre, Perrigo Company PLC reportó unos ingresos de 217.80M USD para el periodo finalizado el 2025-12-31, procedentes del segmento con mejor rendimiento, Upper respiratory. United States aportó los mayores ingresos, alcanzando los 626.40M USD.

Por negocio

Ingresos operativos

Proporción

Anual

Anual

Trimestral

Contract Manufacturing

Upper respiratory

Pain and sleep-aids

Skincare and personal hygiene

Nutrition

Digestive health

Healthy lifestyle

Oral self-care

Vitamins, minerals, and supplements

Other

Women's Health

Animal health

Unallocated

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Contract Manufacturing

270.90M(100.00%)

306.20M(100.00%)

--(--)

262.40M(6.03%)

286.80M(6.90%)

300.50M(100.00%)

Upper respiratory

--(--)

858.30M(18.44%)

823.20M(18.49%)

709.30M(17.14%)

760.90M(17.49%)

806.10M(19.39%)

--(--)

Pain and sleep-aids

--(--)

619.30M(13.30%)

595.20M(13.37%)

607.20M(14.67%)

624.90M(14.36%)

558.80M(13.44%)

--(--)

Skincare and personal hygiene

--(--)

568.70M(12.22%)

620.00M(13.93%)

613.50M(14.82%)

552.40M(12.70%)

562.90M(13.54%)

--(--)

Nutrition

--(--)

563.20M(12.10%)

520.40M(11.69%)

401.90M(9.71%)

388.30M(8.93%)

395.30M(9.51%)

--(--)

Digestive health

--(--)

546.30M(11.73%)

517.00M(11.61%)

513.50M(12.41%)

497.80M(11.44%)

456.30M(10.98%)

--(--)

Healthy lifestyle

--(--)

537.40M(11.54%)

425.30M(9.55%)

477.00M(11.53%)

517.80M(11.90%)

529.90M(12.75%)

--(--)

Oral self-care

--(--)

415.40M(8.92%)

401.50M(9.02%)

407.70M(9.85%)

386.00M(8.87%)

162.90M(3.92%)

--(--)

Vitamins, minerals, and supplements

--(--)

203.00M(4.36%)

219.70M(4.94%)

249.10M(6.02%)

228.00M(5.24%)

208.80M(5.02%)

--(--)

Other

--(--)

177.40M(3.81%)

184.90M(4.15%)

159.50M(3.85%)

132.10M(3.04%)

145.20M(3.49%)

--(--)

Women's Health

--(--)

166.60M(3.58%)

144.20M(3.24%)

--(--)

Animal health

--(--)

43.70M(1.05%)

--(--)

Unallocated

--(--)

Por región

Ingresos operativos

Proporción

Anual

Anual

Trimestral

United States

Europe

All other countries

Ireland

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

United States

2.54B(59.72%)

2.65B(60.58%)

2.92B(62.65%)

2.87B(64.47%)

2.57B(62.00%)

2.58B(63.08%)

2.36B(60.99%)

3.10B(65.48%)

3.27B(66.16%)

3.35B(63.50%)

3.30B(71.76%)

3.29B(81.06%)

2.87B(91.10%)

Europe

1.62B(38.00%)

1.60B(36.69%)

1.62B(34.85%)

1.47B(33.12%)

1.39B(33.66%)

1.35B(33.04%)

1.34B(34.52%)

1.35B(28.48%)

1.31B(26.55%)

1.49B(28.27%)

613.60M(13.33%)

--(--)

All other countries

96.70M(2.27%)

119.50M(2.73%)

116.30M(2.50%)

107.30M(2.41%)

179.80M(4.34%)

158.60M(3.88%)

173.80M(4.49%)

285.80M(6.04%)

330.30M(6.68%)

345.50M(6.54%)

342.70M(7.44%)

622.50M(15.33%)

279.40M(8.87%)

Ireland

--(--)

30.40M(0.61%)

89.10M(1.69%)

344.00M(7.47%)

146.70M(3.61%)

1.00M(0.03%)